Clinical Trials Directory

Trials / Completed

CompletedNCT03408041

Reported Time Between Onset and Diagnosis of Alzheimer's Disease: Correlation With Objective Parameters

Status
Completed
Phase
Study type
Observational
Enrollment
129 (actual)
Sponsor
Murielle Surquin · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The early diagnosis of Alzheimer's disease is essential to enable patients to have access to the available treatments. However, there is a delay between the diagnosis and the onset of symptoms, which can range from 1 year to more than 5 years. In clinical practice, the hippocampal volume, measured by the Scheltens index, is currently used as a marker of the progression of the disease. The purpose of this study is to determine whether the patient's sex, age and ethnicity can influence the delay in the expression of cognitive troubles reported by the family at the first medical consultation, as well as to determine if there is a correlation between the delay reported by the family and the Scheltens index.

Conditions

Interventions

TypeNameDescription
OTHERMedical file data extractionMedical file data extraction

Timeline

Start date
2016-05-01
Primary completion
2017-10-01
Completion
2017-10-01
First posted
2018-01-23
Last updated
2018-01-23

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT03408041. Inclusion in this directory is not an endorsement.